A detailed history of Price T Rowe Associates Inc transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 39,257 shares of MDXG stock, worth $364,304. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39,257
Previous 37,747 4.0%
Holding current value
$364,304
Previous $262,000 11.07%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.65 - $7.76 $8,531 - $11,717
1,510 Added 4.0%
39,257 $233,000
Q2 2024

Aug 14, 2024

BUY
$6.16 - $8.08 $29,377 - $38,533
4,769 Added 14.46%
37,747 $262,000
Q1 2024

May 15, 2024

BUY
$7.61 - $8.63 $28,963 - $32,845
3,806 Added 13.05%
32,978 $254,000
Q4 2023

Feb 14, 2024

SELL
$5.7 - $9.14 $135,984 - $218,052
-23,857 Reduced 44.99%
29,172 $256,000
Q3 2023

Nov 14, 2023

SELL
$6.35 - $8.16 $9,042 - $11,619
-1,424 Reduced 2.62%
53,029 $387,000
Q2 2023

Aug 14, 2023

BUY
$3.14 - $6.61 $4,574 - $9,630
1,457 Added 2.75%
54,453 $360,000
Q1 2023

May 15, 2023

BUY
$2.97 - $4.81 $24,452 - $39,600
8,233 Added 18.39%
52,996 $181,000
Q4 2022

Feb 14, 2023

BUY
$2.63 - $3.45 $33,458 - $43,890
12,722 Added 39.71%
44,763 $124,000
Q3 2022

Nov 14, 2022

BUY
$2.71 - $4.22 $19,257 - $29,987
7,106 Added 28.5%
32,041 $92,000
Q2 2022

Aug 15, 2022

BUY
$3.17 - $5.0 $2,219 - $3,500
700 Added 2.89%
24,935 $87,000
Q1 2022

May 16, 2022

BUY
$4.27 - $6.27 $10,598 - $15,562
2,482 Added 11.41%
24,235 $114,000
Q4 2021

Feb 14, 2022

SELL
$5.7 - $8.48 $176,118 - $262,015
-30,898 Reduced 58.68%
21,753 $131,000
Q3 2021

Nov 15, 2021

SELL
$5.52 - $15.83 $14,351 - $41,158
-2,600 Reduced 4.71%
52,651 $319,000
Q2 2021

Aug 16, 2021

SELL
$9.02 - $12.72 $85,229 - $120,191
-9,449 Reduced 14.6%
55,251 $691,000
Q1 2021

May 17, 2021

BUY
$8.48 - $11.28 $267,968 - $356,448
31,600 Added 95.47%
64,700 $666,000
Q4 2020

Feb 16, 2021

BUY
$5.32 - $10.17 $176,092 - $336,627
33,100 New
33,100 $301,000

Others Institutions Holding MDXG

About MIMEDX GROUP, INC.


  • Ticker MDXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 113,609,000
  • Market Cap $1.05B
  • Description
  • MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...
More about MDXG
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.